MedPath
HSA Approval

CLARYTAS 250 TABLET 250 mg

SIN11742P

CLARYTAS 250 TABLET 250 mg

CLARYTAS 250 TABLET 250 mg

December 6, 2001

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01FA09

clarithromycin

Manufacturer Information

APOTHECA MARKETING PTE LTD

INTAS PHARMACEUTICALS LTD

Intas Pharmaceuticals Ltd.

Active Ingredients

Clarithromycin

250 mg

Clarithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLARYTAS 250 TABLET 250 mg - HSA Approval | MedPath